Click here to read the press release
NULL
đ Legal 500 EMEA 2025 | Squadra Avocats has been ranked in 6 practice areas in the latest edition of Legal 500 EMEA 2025. A warm thank you to our clients for their trust and to our teams for their commitment and team spirit.
NULLPlease click here to view the newsletter
NULLPlease click here to view the newsletter
NULL
Squadra Avocats has recently advised FERPECTION, a start-up specializing in user experience (UX) optimization and quality assurance, on its acquisition by UNGUESS (unguess.io), Italyâs leading crowdtesting platform.
This transaction will enable UNGUESS to establish itself as a European leader in the fields of quality assurance and UX research, bolstered by the integration of FERPECTIONâs portfolio of major clients in the French market, including renowned brands such as Air France, Clarins, LâOrĂŠal, LVMH, Matmut, and SANEF.
FERPECTION was advised by Squadra Avocats, with the Corporate-M&A team led by partners Camille Mirabel-Chambaud and François Lan, and associate Marine Despres.
NULL
Squadra Avocats recently advised DETECTIVE BOX, an innovative startup in the immersive games sector, in a successful âŹ2 million fundraising. This operation will enable DETECTIVE BOX to strengthen its development and position itself as a key player in the board games market, inspired by escape games.
With this fundraising, the startup will accelerate the production of its new game concepts while consolidating its existing activities. This transaction marks a crucial step in its expansion.
DETECTIVE BOX was advised by Squadra Avocats, whose Corporate-M&A team was led by partners Camille Mirabel-Chambaud and François Lan, along with associate Marine Despres.
NULLSquadra Avocats has recently advised MAASH group in its takeover of METEX NĂĂVISTA.
A subsidiary of METabolix Explorer and a leader in the production, by fermentation, of naturally sourced ingredients for use in animal feed, cosmetics, and the biopolymer industry, Metex Nøøvista has been taken over by the Belgian company, Maash, as part of a restructuring procedure.
Metex Nøøvista forms part of Metex group, which uses fermentation to produce naturally sourced ingredients for animal feed and cosmetic products.
Listed on the Paris stock exchange, METabolix Explorer is responsible for carrying out the groupâs research and development activities, as well as its financial activities as a holding company, and holds total ownership of its two operational subsidiaries: METEX NøøvistaGo, which operates a factory that produces amino acids through the fermentation of sugar; and METEX Nøøvista, created in 2018, which has, since March 2021, operated a newly constructed factory situated in Saint-Avold (in Lorraine), capable of producing up to 5000 tonnes of naturally sourced propanediol and up to 1000 tonnes of naturally sourced butyric acid.
METEX Nøøvista was required to open up judicial reorganisation proceedings following a ruling on the 25th of March 2024 from the Paris Commercial Court. A judgement from the Paris Commercial Court on the 25th of June 2024 authorised the handover of METEX Nøøvistaâs assets and business activity to Maash.
Squadra Avocats was represented by Charles Morel and Emilie Rosier.
NULLSquadra (Charles Morel et Emilie Rosier) has recently supported the companies GRAFTYS and BIOLOGICS 4 LIFE in their insolvency proceedings before the Aix-en-Provence Commercial Court.
Graftys specialises in the development of bioresorbable synthetic bone grafts for orthopedic surgery. After carrying out research on biomaterials, the company created a new type of synthetic bone graft, that can be easily injected into the centre of bones in order to repair them. Graftys is now a market leader and has received particular recognition for its work in the US.
In 2021, it acquired another French medtech company, Biologics 4 Life, working in a similar field: the development of injectable biomaterials combined with active ingredients capable of treating and preventing fractures caused by osteoporosis.
Due to a now-resolved regulatory constraint., Graftys had to suspend activity for a number of months in 2023. Faced with financial difficulties at the beginning of 2024, it was necessary for the companies to enter into insolvency proceedings.
